{"entity":{"id":"cell-stem-cell","kind":"journal","name":"Cell Stem Cell","aka":["Cell Stem Cell"],"tldr":"Cell Stem Cell is Cell Press's stem-cell journal. Cancer readers go to it for leukaemia stem cell and clonal haematopoiesis biology, patient-derived organoid biobanks used for drug testing, and induced pluripotent stem cell-derived immune cells for off-the-shelf cell therapies; access is hybrid.","summary":"Cell Stem Cell is Cell Press's stem-cell journal, founded in 2007, appearing monthly and published by Cell Press (Elsevier) on a hybrid model. It publishes haematopoietic and cancer stem cell biology, patient-derived organoid biobanks used for drug testing, and induced-pluripotent-stem-cell-derived immune cells for allogeneic cell therapy. For cancer readers its relevance lies in leukaemia stem cells, clonal haematopoiesis, organoid models and off-the-shelf cell therapies. Within OnCo it is linked from the Patient-derived organoids technology entry and the Michael Teitell biography, and it is where a reader would look for organoid biobank and cell-therapy engineering papers.","asOf":"2026-09-09","links":[{"label":"Cell Press","url":"https://www.cell.com"}],"tags":[],"related":["cell"],"cancers":[],"sections":[],"technologies":["organoids"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"Cell Press (Elsevier)","url":"https://www.cell.com/cell-stem-cell/home","issn":"1934-5909","scope":"stem cell biology","access":"hybrid","founded":2007,"matchNames":["Cell Stem Cell"]},"route":"/journals/cell-stem-cell/","neighbours":{"journal":[{"id":"cell","kind":"journal","name":"Cell","route":"/journals/cell/"}],"technology":[{"id":"organoids","kind":"technology","name":"Patient-derived organoids","route":"/technologies/organoids/"}],"person":[{"id":"michael-teitell","kind":"person","name":"Michael A. Teitell","route":"/people/michael-teitell/"}]}}